SonoSite Announces Alliance with Aloka for Distribution of Its

TITAN System in Japan 
Business Editors
SEATTLE--(BUSINESS WIRE)--June 30, 2004
SonoSite, Inc. (Nasdaq:SONO), the worldwide leader in
high-performance, hand-carried ultrasound, announced today that it has
signed a distribution agreement for Japan with Aloka Co., Ltd., a
leading Japanese manufacturer and distributor of ultrasound systems.
The agreement names Aloka as SonoSite's exclusive distributor for
TITAN(TM), the company's newest generation of high-performance,
hand-carried ultrasound systems, for all of Japan's clinical
ultrasound markets, including cardiology, abdominal, vascular, Ob/Gyn
and emergency medicine. 
"This agreement brings together two leaders in ultrasound," said
Mr. Yoshihiro Yoshikawa, president, Aloka Co. Ltd. "Hand-carried
ultrasound is Japan's most rapidly growing ultrasound market. Aloka is
fully committed to optimizing this major opportunity through this
strategic alliance with SonoSite and to bringing the finest
hand-carried ultrasound available to Japan's medical practitioners." 
"Aloka's history in ultrasound and respected position as a leading
technology innovator make this an exciting partnership for SonoSite,"
said Kevin M. Goodwin, SonoSite president and CEO. "Our agreement with
Aloka is a cornerstone of our strategy to serve the Japanese market by
establishing multiple distribution channels through which SonoSite's
products can be promoted across a broad clinical spectrum. We believe
the market for hand-carried ultrasound systems could eventually equal
or exceed Japan's current market for cart-based systems. We look
forward to working with the Aloka team to further strengthen our
position in and expanding this key market." 
The TITAN system utilizes SonoSite's proprietary ASIC (Application
Specific Integrated Circuit) technology to integrate millions of
transistors onto one circuit, thereby reducing size while offering
excellent image quality and performance in a highly durable design.
Weighing only 7.7 pounds (3.5 kg), the TITAN system boots up in
12-seconds, is easy to use and can be hand-carried to wherever it is
needed to immediately deliver patient care efficiently and
effectively. 
Japan is the world's second largest ultrasound market, and
according to Aloka, accounted for an estimated $400 million in sales
in 2003. The agreement with Aloka follows other steps SonoSite has
taken in recent months to expand its presence in Japan. In February
2004, the company opened SonoSite Japan KK, a wholly owned subsidiary
to provide customer service, quality assurance, sales support and
direct sales into certain clinical segments. Earlier this year,
SonoSite also signed an agreement with Olympus Corporation targeted at
the Japanese endoscopy market. 
About SonoSite 
SonoSite, Inc. (www.sonosite.com), headquartered near Seattle, is
the innovator and worldwide market leader in high-performance,
hand-carried ultrasound technology. By creating modular, compact
systems that meet customer needs, SonoSite is removing barriers to the
use of ultrasound across medicine and positively impacting the
cost-effectiveness and efficiency of ultrasound use. With more than
15,000 units sold worldwide since 1999, SonoSite's products have
become known for exceptional durability with a high design value. 
About Aloka 
Aloka Co., Ltd. (www.aloka.com), headquartered in Tokyo and a
leading manufacturer of medical devices, introduced its first
diagnostic ultrasound system in 1960. With more than 50 years in
medical diagnostic ultrasound, Aloka is recognized as one of the most
experienced and innovative companies in the diagnostic ultrasound
market. Aloka introduced color Doppler technology to the ultrasound
industry in 1983, which today has become an indispensable diagnostic
tool for many ultrasound examinations in a wide range of clinical
applications. 
Forward-looking Information and the Private Litigation Reform Act
of 1995 
Certain statements in this press release relating to the market
acceptance of our products, possible future sales relating to expected
orders, and our future financial and operations results are
"forward-looking statements" for the purposes of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on the opinions and
estimates of our management at the time the statements are made and
are subject to risks and uncertainties that could cause actual results
to differ materially from those expected or implied by the
forward-looking statements. These statements are not guaranties of
future performance and are subject to known and unknown risks and
uncertainties and are based on potentially inaccurate assumptions.
Factors that could affect the rate and extent of market acceptance of
our products, the receipt of expected orders, and our financial
performance include our ability to accurately forecast customer demand
for our products, our ability to manufacture and ship our systems in a
timely manner to meet customer demand, timely receipts of regulatory
approvals to market and sell our products, the willingness of
healthcare providers who do not currently use ultrasound to use
ultrasound, the extent to which healthcare insurers reimburse
providers for ultrasound procedures, regulatory changes in various
national health care markets, constraints in government and public
health spending, the ability of our distribution partners to market
and sell our products, as well as other factors described under the
heading, "Important Factors that May Affect Our Business, Our Results
of Operating and Our Stock Price," included in our latest periodic
report filed with the Securities and Exchange Commission. We caution
readers not to place undue reliance upon these forward-looking
statements that speak only as to the date of this release. We
undertake no obligation to publicly revise any forward-looking
statements to reflect new information, events or circumstances after
the date of this release or to reflect the occurrence of unanticipated
events. 
CONTACT:
SonoSite
Mike Schuh, CFO, 425-951-1333
or
EVC Group
Anne Bugge, 206-926-5220
or
SonoSite Japan KK
Tomo Hasegawa, 81.3-5304-5337
 
 
Press spacebar to pause and continue. Press esc to stop.